BioLife Products to Showcase Patented Oral Peptide Delivery Technology at London Life Sciences Week 2026 BioLife Products Limited will present its patented oral peptide delivery technology and recent intellectual property…
Sun Nuclear Launches Simon Cloud-Based Platform to Monitor Linear Accelerator Health and Strengthen Radiation Therapy Quality Assurance Sun Nuclear, a Mirion Medical company, has announced the global launch of Simon™,…
Mirum Pharmaceuticals Reports Strong Third-Quarter 2026 Results, Raises Full-Year Sales Guidance and Advances Rare Disease Pipeline Mirum Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing treatments for rare…
Imperative Care Reports Comparable Outcomes in Women and Men Following Symphony Thrombectomy for Intermediate-Risk Pulmonary Embolism Imperative Care, a medical technology company focused on advancing the treatment of thromboembolic disease,…
Ropeginterferon Alfa-2b Gains ET Approvals Across Major Global Markets, Broadening Treatment Access for Patients PharmaEssentia Corporation’s blood cancer treatment, ropeginterferon alfa-2b (Ropeg), is expanding its presence in the global market…
City of Hope and Collaborators Report Promising Phase 1 Results for SER-155, a 16-Strain Live Biotherapeutic Designed to Prevent Bloodstream Infections in Stem Cell Transplant Patients City of Hope®, one…
Agenus Reports Promising Phase 2 UNICORN Trial Results for Neoadjuvant Botensilimab and Balstilimab in Resectable Colon Cancer Published in Nature Medicine Agenus Inc., a biotechnology company focused on developing innovative…
VintaBio Invites Competitive Bids for Philadelphia cGMP Manufacturing Facility, Viral Vector Technology and Proprietary Bioprocessing Assets VintaBio, Inc., a company specializing in advanced viral vector and vaccine manufacturing, has announced…
Kairos Pharma Presents ENV-105 Clinical Progress and Positive Interim Phase 2 Results at International Cancer Research Conference Kairos Pharma, Ltd., a clinical-stage biopharmaceutical company focused on developing innovative treatments to…
Pretzel Therapeutics Receives UK MHRA Authorization for PX578 Phase 2 Trial in POLG-Mediated Mitochondrial Disease Pretzel Therapeutics, Inc., a clinical-stage biotechnology company developing a new class of medicines intended to…
Enhertu Receives 2026 International Prix Galien Award for Best Biotechnology Product Enhertu, a HER2-directed antibody drug conjugate (ADC) discovered by Daiichi Sankyo and jointly developed and commercialized by Daiichi Sankyo…
Latus Bio Presents New Preclinical Gene Therapy Data for CNS and Kidney-Targeting AAV Capsids at ESGCT 2026 Latus Bio, Inc., a biotechnology company focused on engineering and developing advanced gene…